newsfilter
← Latest News
GlobeNewswire·

Alaunos Therapeutics Reports First Quarter 2023 Financial Results

Actively enrolling patients and manufacturing cryopreserved products for TCR-T Library Phase 1/2 trial; expect to report interim data in the third quarter of 2023Fully prepaid loan with Silicon Valley Bank; now a